Clinical Validation of Sophia Genetics Assay

Not yet recruitingOBSERVATIONAL
Enrollment

248

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Ovarian CancerBreast CancerLynch SyndromeIntestinal Polyposis
Interventions
DIAGNOSTIC_TEST

Sophia Herditary Cancer Solution

To compare the performance of MGI's DNBSEQ-G400 sequencing instrument with the gold standard Illumina instruments (MiSeq and NextSeq 550) using the same capture DNA libraries constructed with Sophia Genetics assays.

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER